Pharmacokinetic Interactions Between Tegoprazan and the Combination of Clarithromycin, Amoxicillin and Bismuth in Healthy Chinese Subjects: An Open-Label …

Y Du, L Yu, B Deng, Q Li, J Hu, L Li, Y Xu… - Clinical Drug …, 2024 - Springer
Background Tegoprazan is a potassium-competitive acid blocker that inhibits gastric acid
and which may be used for eradicating Helicobacter pylori. This study focuses on the …

Pharmacokinetic Interactions Between Tegoprazan and the Combination of Clarithromycin, Amoxicillin and Bismuth in Healthy Chinese Subjects: An Open-Label …

Y Du, L Yu, B Deng, Q Li, J Hu, L Li… - Clinical drug …, 2024 - pubmed.ncbi.nlm.nih.gov
Background Tegoprazan is a potassium-competitive acid blocker that inhibits gastric acid
and which may be used for eradicating Helicobacter pylori. This study focuses on the …

Pharmacokinetic Interactions Between Tegoprazan and the Combination of Clarithromycin, Amoxicillin and Bismuth in Healthy Chinese Subjects: An Open-Label …

Y Du, L Yu, B Deng, Q Li, J Hu, L Li, Y Xu… - Clinical Drug …, 2024 - europepmc.org
Background Tegoprazan is a potassium-competitive acid blocker that inhibits gastric acid
and which may be used for eradicating Helicobacter pylori. This study focuses on the …